pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
enekinragene inzadenovec
Osteoarthritis
$PCRXPacira BioSciences, Inc.
0 catalysts
Phase 2
engasertib
engasertib [INN]
Hereditary Hemorrhagic Telangiectasia (Osler–Weber–Rendu Disease)
Vaderis Therapeutics AG
0 catalysts
Phase 2
eniluracil
Metastatic Breast Cancer
Dihydropyrimidine dehydrogenase [NADP(+)]
$PCSAProcessa Pharmaceuticals, Inc.
0 catalysts
← prev
page 208 of 271
next →
131
Pain89
Neurology1
Phase 3
enlicitide decanoate
Heterozygous Familial Hypercholesterolemia (heFH)
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
enobosarm
Obesity
Androgen receptor
$VERUVERU INC.
0 catalysts
Phase 2
enozertinib
enozertinib [INN]
Solid Tumor
$ORICOric Pharmaceuticals, Inc.
0 catalysts
Marketed
ensifentrine
Ohtuvayre (ensifentrine)
Bronchiectasis
Phosphodiesterase 3Phosphodiesterase 4
Verona Pharma Ltd
0 catalysts
pre_registration
ensitrelvir fumarate
Coronavirus Disease 2019 (COVID-19)
$SGIOFSHIONOGI & CO LTD
0 catalysts
Marketed
entacapone
Entacapone AvKare (entacapone)
Parkinson's Disease
AvKare LLC
0 catalysts
Marketed
entecavir
Entecavir (entecavir)
Hepatitis B
Carlsbad Technology Inc
0 catalysts
Phase 3
entolimod
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Toll-like receptor 5
$TIVCTivic Health Systems, Inc.
0 catalysts
Marketed
entrectinib
Rozlytrek (entrectinib)
Non-Small Cell Lung Cancer
ALK tyrosine kinase receptorNeurotrophic tyrosine kinase receptor
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 3
envudeucitinib
Plaque Psoriasis (Psoriasis Vulgaris)
$ALMSALUMIS INC.
0 catalysts
Phase 2
enzomenib tartrate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Sumitomo Pharma Co Ltd
0 catalysts
Phase 2
epaldeudomide
epaldeudomide [INN]
Systemic Lupus Erythematosus
Kangpu Biopharmaceuticals Ltd
0 catalysts
Phase 2
epeleuton
epeleuton [INN]
Sickle Cell Disease
Afimmune Biopharma Ltd
0 catalysts
Phase 2
epetraborole
epetraborole [INN]
Mycobacterium avium Infections
$ANTXAN2 Therapeutics, Inc.
0 catalysts
Marketed
epinastine hydrochloride
Epinastine Hydrochloride (epinastine hydrochloride)
Allergic Conjunctivitis
Somerset Therapeutics LLC
0 catalysts
Marketed
epinephrine Fresenius
Epinephrine (epinephrine)
Anaphylaxis
Fresenius Kabi USA LLC
0 catalysts
Marketed
epoetin alfa
Epogen (epoetin alfa)
Chemotherapy Induced Anemia
$AMGNAMGEN INC
0 catalysts
Preclinical
epoetin beta
Cardiac Arrest
$RTXRTX Corp
0 catalysts
Marketed
epoetin zeta
Retacrit (epoetin zeta-efbx)
Anemia in Chronic Kidney Disease (Renal Anemia)
Vifor Pharma Inc
0 catalysts
Preclinical
epoprostenol
Aurora Research Institute LLC
0 catalysts
Marketed
eposin
Etoposide (etoposide)
Small-Cell Lung Cancer
Meitheal Pharmaceuticals Inc
0 catalysts
Phase 2
epsametostat
epsametostat [INN]
Peripheral T-Cell Lymphomas (PTCL)
Shanghai Haihe Biopharma Co Ltd
0 catalysts
Marketed
eptifibatide
Eptifibatide (eptifibatide)
Acute Coronary Syndrome
Athenex Pharma Solutions LLC (Inactive)
0 catalysts
Marketed
eptinezumab
Vyepti (eptinezumab-jjmr)
Migraine
H. Lundbeck AS
0 catalysts
Marketed
eravacycline dihydrochloride
Xerava (eravacycline dihydrochloride)
Complicated Intra-Abdominal Infections
La Jolla Pharmaceutical Company
0 catalysts
Phase 3
ercanetide
ercanetide [INN]
Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome)
Neuren Pharmaceuticals Ltd
0 catalysts
Marketed
erenumab
Aimovig (erenumab-aooe)
Migraine
$AMGNAMGEN INC
0 catalysts